News & Views
Bill Burns Appointed as Non Executive Director
May 07 2010
Shire plc (Dublin) a specialty biopharmaceutical company has appointed Bill Burns to its Board as a Non Executive Director with immediate effect. Mr Burns has also been appointed a member of Shire’s Remuneration Committee. Mr Burns has a long and distinguished career in the global pharmaceuticals industry, most recently as CEO of Roche’s Pharmaceuticals Division and as a member of the Roche Group Corporate Executive Committee. He was involved in the acquisition and privatisation of Genentech, led the integration of Boehringer Mannheim Therapeutics and played a lead role in the negotiations resulting in Roche becoming a majority owner of Chugai in Japan. Following retirement in January this year, he has since been appointed to the Board of Directors of Roche Holdings Ltd and is a Board member of bothChugai Pharmaceuticals and of Genentech Inc.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 03 2024 Gandhinagar, India
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA